Dr.Finance Statistics

Total Valuation

Dr.Finance has a market cap or net worth of PLN 3.14 million. The enterprise value is 2.94 million.

Market Cap	3.14M
Enterprise Value	2.94M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Dr.Finance has 3.74 million shares outstanding.

Current Share Class	3.74M
Shares Outstanding	3.74M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	45.16%
Owned by Institutions (%)	n/a
Float	1.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.33
PB Ratio	16.29
P/TBV Ratio	16.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.62
EV / Sales	0.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.11.

Current Ratio	2.08
Quick Ratio	1.43
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-221.27

Financial Efficiency

Return on equity (ROE) is -88.65% and return on invested capital (ROIC) is -42.72%.

Return on Equity (ROE)	-88.65%
Return on Assets (ROA)	-22.91%
Return on Invested Capital (ROIC)	-42.72%
Return on Capital Employed (ROCE)	-126.24%
Revenue Per Employee	4.71M
Profits Per Employee	-153,100
Employee Count	1
Asset Turnover	14.20
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.03% in the last 52 weeks. The beta is 1.27, so Dr.Finance's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+29.03%
50-Day Moving Average	0.63
200-Day Moving Average	0.70
Relative Strength Index (RSI)	62.99
Average Volume (20 Days)	10,161

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr.Finance had revenue of PLN 9.43 million and -306,200 in losses. Loss per share was -0.08.

Revenue	9.43M
Gross Profit	9.08M
Operating Income	-243,400
Pretax Income	-306,200
Net Income	-306,200
EBITDA	-242,000
EBIT	-243,400
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 218,000 in cash and 21,400 in debt, giving a net cash position of 196,600 or 0.05 per share.

Cash & Cash Equivalents	218,000
Total Debt	21,400
Net Cash	196,600
Net Cash Per Share	0.05
Equity (Book Value)	192,900
Book Value Per Share	0.05
Working Capital	192,500

Full Balance Sheet

Cash Flow

Operating Cash Flow	-161,800
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 96.28%, with operating and profit margins of -2.58% and -3.25%.

Gross Margin	96.28%
Operating Margin	-2.58%
Pretax Margin	-3.25%
Profit Margin	-3.25%
EBITDA Margin	-2.57%
EBIT Margin	-2.58%
FCF Margin	n/a

Dividends & Yields

Dr.Finance does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.75%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 1, 2016. It was a reverse split with a ratio of 0.01.

Last Split Date	Jul 1, 2016
Split Type	Reverse
Split Ratio	0.01

Scores

Dr.Finance has an Altman Z-Score of 17.93 and a Piotroski F-Score of 4.

Altman Z-Score	17.93
Piotroski F-Score	4